Stocktoria

Centessa Pharmaceuticals plc CNTA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-05-28 · LEI

Centessa Pharmaceuticals plc statistics & valuation

Market cap$6.3B
P / B11.9×
Net margin-1316.9%
Return on equity-37.5%
FCF margin-1294.6%
Net debt$48.8M
Enterprise value USD$6.3B
Earnings yield EBIT/EV-3.3%
Return on capital-32.2%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-2204.70% -1316.90% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-2499.40% -1384.60% 202020212022202320242025
Return on equity (%)
-77.50% -64.30% -64.00% -58.70% -37.50% 202020212022202320242025
Shares outstanding
0 90.0M 94.8M 98.8M 132.6M 149.2M 202020212022202320242025
Net debt ($)
-$7.2M -$519.4M -$323.8M -$52.3M -$274.3M $48.8M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-91.00% -60.50% -48.70% -41.90% -40.90% -28.70% 202020212022202320242025
Free cash flow margin (%)
-2342.20% -1294.60% 202020212022202320242025
Debt / equity (×)
0.15× 0.21× 0.32× 0.27× 0.21× 202020212022202320242025
EPS ($)
-$5.07 -$2.31 -$1.57 -$2.06 -$1.46 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-1384.6%—-2499.4%———
Net margin-1316.9%—-2204.7%———
FCF margin-1294.6%—-2342.2%———
Return on assets-28.7%-40.9%-41.9%-48.7%-60.5%-91.0%
Return on equity-37.5%-58.7%-64.0%-64.3%-77.5%—
Debt / equity0.21×0.27×0.32×0.21×0.15×—
Current ratio8.579.258.0011.4225.521.30

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.